What is PTC Therapeutics's interest expense?

PTC Therapeutics (PTCT) reported interest expense of -$49.03M in Q1 2026.

How has PTC Therapeutics's interest expense changed year-over-year?

PTC Therapeutics's interest expense decreased by 43.8% year-over-year, from -$34.09M to -$49.03M.

What is the long-term trend for PTC Therapeutics's interest expense?

Over 4 years (2021 to 2025), PTC Therapeutics's interest expense has grown at a 15.3% compound annual growth rate (CAGR), from -$86.02M to -$152.23M.

What does interest expense mean?

Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

PTC Therapeutics PTCT Interest Expense

Interest Expense at other companies

BioMarin PharmaceuticalsBMRN

$14.96M+422%

BridgeBio PharmaBBIO

$12.94M-28.6%

Arrowhead ResearchARWR

$23.85M+10.2%

United TherapeuticsUTHR

$3M-50.8%

ALN

Alnylam PharmaceuticalsALNY

——

BiogenBIIB

——

Segments

By segment

See full

Life Science$67.02M+30.5%

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's interest expense?: PTC Therapeutics (PTCT) reported interest expense of -$49.03M in Q1 2026.
How has PTC Therapeutics's interest expense changed year-over-year?: PTC Therapeutics's interest expense decreased by 43.8% year-over-year, from -$34.09M to -$49.03M.
What is the long-term trend for PTC Therapeutics's interest expense?: Over 4 years (2021 to 2025), PTC Therapeutics's interest expense has grown at a 15.3% compound annual growth rate (CAGR), from -$86.02M to -$152.23M.
What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.